| Literature DB >> 24332477 |
Sung-Min Moon1, Jae-Sung Kim1, Heung-Joong Kim1, Mi Suk Choi2, Bo Ram Park1, Su-Gwan Kim1, Hoon Ahn3, Hong Sung Chun4, Yong Kook Shin5, Jong-Jin Kim6, Do Kyung Kim1, Sook-Young Lee1, Young-Woo Seo7, Yong Hwan Kim8, Chun Sung Kim9.
Abstract
A novel fibrinolytic enzyme was purified from Lyophyllum shimeji, a popular edible mushroom in Asia. The enzyme was purified using combination of anion exchange chromatography on a Mono Q 5/5 column and size exclusion gel filtration chromatography on Superdex 200 100/300 column. This purification protocol resulted 80.9-fold purification of the enzyme and a final yield of 5.7%. The molecular weight of the purified enzyme was estimated to be 21 kDa by SDS-PAGE and size exclusion gel filtration. The N-terminal amino acid sequence was found to be ITFQSASP, which is dissimilar from that of known fibrinolytic enzymes. The purified enzyme was a neutral protease with an optimal reaction pH and temperature of 8.0 and 37°C, respectively. Enzymatic activity was inhibited by Cu(2+) and Co(2+). It was also significantly inhibited by PMSF and TPCK. Furthermore, it was found to exhibit a higher specificity for S-7388, a well-known chymotrypsin chromogenic substrate, indicating chymotrypsin like serine metalloprotease. The relative fibrinolytic activity of 5 μg purified enzyme have two fold more activity than 1 unit/ml of plasmin on fibrin plate. Furthermore, purified enzyme preferentially hydrolyzed the Aα-chain followed by the Bβ- and γ-chain of fibrinogen, which is precursor of fibrin. Therefore, these data suggests that the fibrinolytic enzyme derived from edible mushroom, L. shimeji, might be useful for thrombolytic therapy and preventing thrombotic disease.Entities:
Keywords: Edible mushroom; Fibrinogenolysis; Fibrinolysis; Lyophyllum shimeji; Thrombosis
Mesh:
Substances:
Year: 2013 PMID: 24332477 DOI: 10.1016/j.jbiosc.2013.10.019
Source DB: PubMed Journal: J Biosci Bioeng ISSN: 1347-4421 Impact factor: 2.894